Skip to main content
. 1998 Sep;42(9):2240–2244. doi: 10.1128/aac.42.9.2240

TABLE 2.

Life table analysis of percentage of patients developing cidofovir resistance

IC50 and culture source (n = 13) % of patients for time on therapy (mo)
3 6 9 12
>2 μM
 Blood 20 20 20 100a
 Urine 8 8 8 8
 Blood or urine 29 29 29 100
>2.5 μM
 Blood 20 20 20 20
 Urine 0 0 0 0
 Blood or urine 20 20 20 20
a

Only one patient remained on cidofovir beyond 6 months.